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Accepted 17 April 2015Renal dysfunction is a severe complication that is caused by diabetes mellitus. Many factors
associate the progression of this complication with high levels of proinflammatory and
pro-oxidant substances, such as advanced glycation end products (AGEs), which form a
heterogeneous group of compounds that can accumulate in tissues such as retinas, joints, and
kidneys. The hypothesis of this study is that n-3 polyunsaturated fatty acids (n-3 PUFAs) have
a nephroprotective effect on rats after exposing them to a combination of 2 protocols that
increase the AGE amounts: a high-fat diet enrichedwith AGEs and a diabetes rat model. Adult
Wistar rats were divided into 6 groups that received the following diets for 4 weeks: (1) control
group; 2) HAGE: high AGE fat–containing diet group; (3) HAGE + n-3: high AGE fat–containing
diet plus n-3 PUFAs group; (4) diabetic group; (5) Db + HAGE: high AGE fat–containing diet
diabetic group; and (6) Db + HAGE + n-3: high AGE fat–containing diet plus n-3 PUFAs diabetic
group. Diabetes mellitus was induced by an intraperitoneal injection of alloxan (150 mg kg−1).
In diabetic and nondiabetic rats, the high HAGE fat–containing diet increased the serum
creatinine, tumor necrosis factor–α, thiobarbituric acid reactive substances, and reactive
oxygen species levels, as well as the superoxide dismutase/catalase + glutathione peroxidase
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513N U T R I T I O N R E S E A R C H 3 5 ( 2 0 1 5 ) 5 1 2 – 5 2 2immunocontent of the kidneys. n-3 Polyunsaturated fatty acids attenuated these alterations
and influenced the receptor for advanced glycation end products/oxidative stress/tumor
necrosis factor–α axis. In summary, this study showed that the extrinsic AGE pathway
(HAGE diet) had a greater effect on renalmetabolism than the intrinsic AGE pathway (diabetes
induction) and that n-3 PUFAs appear to prevent renal dysfunction via antioxidant and anti-
inflammatory pathways.
© 2015 Elsevier Inc. All rights reserved.1. Introduction
The increasing incidence of age-related chronic diseases, most
notably neurodegenerative disorders, obesity, diabetes, and
inflammatory disorders, is a major public health concern [1].
Although the pathophysiology of these diseases is not com-
pletely understood, they have been associated with diets that
promote imbalanced oxidative and/or inflammatory homeo-
stasis [2,3]. Accordingly, impaired renal function in diabetes
patients is associated with high levels of plasmatic cellular
markers of inflammation and oxidative stress [4,5].
Advancedglycation endproducts (AGEs) comprise a groupof
compounds with pro-oxidant and proinflammatory actions
that bind to the receptor for advanced glycation end products
(RAGE) [6,7]. These compoundsmay be endogenously produced
or exogenously acquired. They are produced in the body under
physiological conditions via a reaction among reducing sugars
or reactive aldehydes with the free amino groups of proteins,
lipids, and nucleic acids [8]; their endogenous formation is
markedly enhanced in diseases such as diabetesmellitus [7]. In
addition, these compounds may be present in foods [9] and
cigarette smoke [10]. The amounts of AGEs and other pro-
oxidants in the diet are dependent on the dietary concentra-
tions of proteins, lipids, and carbohydrates [9] and on the
exposure of food to heat [11]. There is a close association
between the AGE content in diets and the serum levels of AGEs,
reactive oxygen species (ROS), and inflammatory mediators in
healthy subjects and in diabetic and renal failure patients [9,12].
The major detoxification enzymes involved in AGE clearance
are glyoxalase I (GLO1) and II [13].
Eicosapentaenoic acid (EPA) belongs to the omega-3 poly-
unsaturated fatty acid (n-3 PUFA) group. Recent studies have
shown that dietary supplementation with n-3 PUFAs retards
the progression of renal diseases in humans and animals
[14,15]. Eicosapentaenoic acid was reported to improve the
albuminuria of type 2 diabetes patients [16]. However, the role
of EPA in the progression of renal dysfunction is not fully
understood. It is hypothesized that thenephroprotective effects
of n-3 PUFAs may be exerted through the modulation of
antioxidant enzymes and by decreasing the ROS [17], thereby
promoting a reduction in proinflammatory cytokines via the
downregulation of nuclear factor–kappa B (NF-κB) [18]. Several
studieswithmetabolic diseases, as in this study, used n-3 alone
and in large quantities (3%-15% of the diet) to potentialize the
beneficial effect of this PUFA [19,20]. In a recent study, a
Japanese group showed that TAK085 (a capsule that contains a
combination of EPA + docosahexaenoic acid [DHA]) increased
DHA levels in the plasma, liver, and kidney, whereas EPA
administration isolated increasedDHA levels in the plasmaand
liver but not in the kidney [21].Our group previously demonstrated that normal rats receiving
a high-fat diet enrichedwithAGEs presented an increase in brain
DNA damage and hepatic lipoperoxidation compared with rats
receiving a high-fat diet [22]. Moreover, our group also demon-
strated the beneficial effects of n-3 PUFAs on oxidative damage
and lipid profiles in the livers of diabetic rats [23].
Based on this information, the hypothesis of this study is that
the combination of the 2 protocols that increase AGE amounts in
rats promotes dysfunction in renal metabolism; in addition, our
hypothesis is also that n-3 PUFAs could exert a nephroprotective
effect against this situation. To test our hypothesis, adult rats
were submitted to a high AGE fat–containing diet (HAGE)
(extrinsic pathway) and/or experimental diabetes induction
(intrinsic pathway) with the aim of increasing the AGE levels
and inducing their consequent effects. The specific objectives
were verified through the effects of these 2 in vivo experimental
interventions on (a) the AGE homeostasis, (b) the redox meta-
bolism, and (c) the inflammatory status after exposure to our
experimental protocols.2. Methods and materials
2.1. Ethics statement
All experiments were approved by the local Ethics Commis-
sion (CEUA/UFRGS) under project number 19183 and followed
the National Institutes of Health Guide for the Care and Use of
Laboratory Animals (NIH publication no. 80-23, revised 1996).
2.2. Chemicals
Alloxan monohydrate and all other chemicals were pur-
chased from Sigma-Aldrich (St Louis, MO, USA). The anti-
bodies anti–superoxide dismutase (SOD) 2, anti-RAGE, and
anti–β-actin were purchased from Calbiochem (Gibbstown,
NJ, USA), Abcam (Cambridge, MA, USA), and Sigma-Aldrich
(St. Louis, MO, USA), respectively.
2.3. Animals
Adult male Wistar rats (60 days old) from our Central Animal
House were maintained under a standard dark/light cycle
(the lights were on between 7:00 AM and 7:00 PM) at room
temperature (22°C ± 2°C).
2.4. Treatments and diets
The rats were divided into 2 groups (n = 30 per group) after 8
hours of fasting (Fig. 1). One group received an intraperitoneal
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(saline) to induce diabetesmellitus, and the other group received
saline. After 1 week, the glycemia of the rats in a fasting state
(8 hours) was evaluated. After confirming the induction of
diabetes (hyperglycemia) by alloxan, each group was subdivided
into 3 subgroups (n = 10 per group) as follows: (1) control or
diabetic—groups that received standard laboratory rat chow;
(2) HAGE or Db + HAGE—groups that received a high fat–
containing diet enriched with AGEs (by heating the diet for 60
minutes at 180°C), and (3)HAGE+n-3 orDb+HAGE+n-3—groups
that received a high fat–containing diet enriched with AGEs and
supplemented with n-3 fatty acids after heating. The heating
regimen of the diets was based on the study by Sandu et al [24],
which found a high AGE content (approximately 1 U/μg) in a
heated high-fat diet. Table shows the dietary compositions as
described by Horwitz et al [25]. During the 4-week dietary
treatment, the animals had free access to food and water.
2.5. Tissue preparation
After 4 weeks of dietary treatments, the rats were fasted for 8
hours and then killed by decapitation. Their blood was immedi-
ately collected in heparinized tubes. The whole blood samples
were then centrifuged at 2500g for 10 minutes at 20°C to yield
the serum fraction, which was used for subsequent bio-
chemical analyses. The kidneys were dissected and homoge-
nized (1 g/5mL) in phosphate/saline buffer (20mmol/L, pH 7.4) or
in Laemmli sample buffer (62.5mmol/L Tris/HCl, pH 6.8; 1% [w/v]Saline
Alloxan
150 mg/kg
Con
 HAGE
 HAG
Diabe
 Db+HAG
 Db+HA
Adult Male Wistar Rats
(60 days old)
Adult Male Wistar Rats
(60 days old)
Blood glucose
measurements
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Fig. 1 – Experimental models.After 8 hours of fasting, rats were d
intraperitoneal saline (0.9% NaCl) or alloxan (150 mg/kg) in salin
groups (n = 10/group), as follows: nondiabetic rats receiving a con
and a high-fat diet enriched with AGEs + n-3 (HAGE + n-3), and d
enriched with AGEs (Db + HAGE), and a high-fat diet enriched wisodium dodecyl sulfate; and 10% [v/v] glycerol) and stored at
−80°C to investigate biochemical parameters or for Western
blotting, respectively [26].
2.6. Serum biochemical parameters
The serum glucose and creatinine levels weremeasured using
commercial kits (Labtest, MG, Brazil) and a SpectraMax M5
microplate reader (Molecular Devices, CA, USA) [22].
2.7. AGEs homeostasis assays
2.7.1. N-(Carboxymethyl)lysine levels
The kidney AGE levels were determined by measuring the
levels of the best-characterized AGE N-(Carboxymethyl)lysine
(N-(CM)L) using a sandwich enzyme-linked immunosorbent
assay anti-CML antibodies according to the manufacturer's
instructions (R&D Systems, Minneapolis, MN, USA) [27]. After
homogenization, kidney samples were centrifuged; an aliquot
of the supernatant was reserved for protein measurement, and
the remaining sample was stored at −80°C for further N-(CM)L
quantification. The results are expressed as picograms per
milligram protein.
2.7.2. GLO1 activity
Glyoxalase I activity (EC 4.4.1.5) was assessed according to
Mannervik et al [28]. The 200-μL/well reaction mixture contain-
ing 50 mmol/L sodium phosphate buffer, pH 7.2; 2 mmol/Ltrol
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ivided into 2 groups (n = 30 per group), which received
e, respectively. After 1 week, the rats were divided into 6
trol diet (control), a high-fat diet enriched with AGEs (HAGE),
iabetic rats receiving a control diet (Db), a high-fat diet
th AGEs + n-3 (Db + HAGE + n-3).
Table – Ingredient composition of the diets fed to rats
Composition Control diet (g/kg) HAGE fat–containing diet (g/kg) HAGE fat–containing diet + n3 (g/kg)
Commercial bran a – 205.0 205.0
Soy protein isolate b 270.0 159.0 159.0
Corn starch 550.5 – –
Sucrose 50.0 200.0 200.0
Vitamin mix c 10.0 10.0 10.0
Mineral salt mix d 40.0 20.0 20.0
DL-Methionine e 3.0 3.0 3.0
DL-Lysine f 3.0 3.0 3.0
Soy oil (mL) g 5.0 10.0 10.0
Lard h – 390.0 360.0
Fish oil i (mL) – – 60.0
Fatty acids
Saturated 0.8 18.29 17.26
Monounsaturated 1.15 21.47 20.54
Polyunsaturated 2.9 11.55 14.82
Total fatty acids 4.85 51.31 52.52
Salt and vitamin compositions are according to Horwitz.
a Bran of standard diet for rodents (Nuvilab CR1, Nuvital, Brazil).
b Soy protein isolate, purity 97% (from Solae, Brazil).
c Vitaminmixture:milligrams per 100 g diet (from Roche, São Paulo, Brazil): vitamin A (retinyl acetate), 4; vitamin D (cholecalciferol), 0.5; vitamin E
(DL-α-tocopheryl acetate), 10; menadione, 0.5; choline, 200; PABA, 10; inositol, 10; niacin (nicotinic acid), 4; pantothenic acid (calcium D-pantothenate), 4;
riboflavin, 0.8; thiamin (thiamine hydrochloride), 0.5; pyridoxine (pyridoxine hydrochloride), 0.5; folic acid, 0.2; biotin [D-(+)-biotin], 0.04; vitamin B12, 0.003.
d Mineral salt mixture: milligrams per 100 g diet (from Roche, São Paulo, Brazil): NaCl, 557; KI, 3.2; KH2PO4, 1556; MgSO4, 229; CaCO3, 1526;
FeSO4–7H2O, 108; MnSO4–H2O, 16; ZnSO4–7H2O, 2.2; CuSO4–5H2O, 1.9; CoCl–6H2O, 0.09.
e DL-Methionine (from Merck, Rio de Janeiro, Brazil).
f DL-Lysine (from Merck, Rio de Janeiro, Brazil).
g Soy oil: fatty acid composition (grams): total lipids, 0.97; saturated lipids, 0.16;monounsaturated lipids, 0.23; polyunsaturated lipids, 0.58; (Liza, Brazil).
h Lard: fattyacid composition (grams): total lipids, 0.95; saturated lipids, 0.39;monounsaturated lipids, 0.45; polyunsaturated lipids, 0.11; (COTRIJUI, Brazil).
i Fishoil: fatty acid composition (grams): total lipids, 1.0;monounsaturated lipids, 0.1; polyunsaturated lipids, 0.6; DHA, 0.5; EPA, 0.1 (Naturalis SA, Brazil).
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bated for 30 minutes at room temperature. Kidney samples
containing 10 to 20μg proteinwere then added to eachwell. The
formation of S-(D)-lactoylglutathione was monitored at 240 nm
for 15 minutes at 25°C. One unit of GLO1 activity is defined as the
amount of enzyme that catalyzes the formation of 1 μmol S-(D)-
lactoylglutathione per minute. The specific activity was ex-
pressed in units per milligram protein.
2.8. Redox parameters
2.8.1. ROS levels
Toassess theROS levels, 2′,7′-dichlorofluorescein (DCFH-DA)was
used as a probe [29]. Esterases from kidney samples cleave the
acetate groups of DCFH-DA to the reducedprobe (DCFH). Reactive
oxygen species in the samples may lead to DCFH oxidation,
yielding the fluorescent product DCF. An aliquot of the kidney
sample (120 μg) was incubated with DCFH-DA (100 μmol/L) at
37°C for 30 minutes. The formation of fluorescent DCF was
monitoredat excitationandemissionwavelengthsof 488and525
nm, respectively, using a fluorescence spectrophotometer. The
ROS contents were quantified using a DCF standard curve. The
results are expressed as nanomoles DCF formed per milligram
protein.
2.8.2. Protein carbonyl content
The oxidative damage to proteins was measured by quanti-
fying the number of carbonyl groups through a reaction with
2,4-dinitrophenylhydrazine. The protein (1 mg) in the kidneysamples was precipitated by 20% trichloroacetic acid and
dissolved in 10 mmol/L 2,4-dinitrophenylhydrazine. The absor-
bancewas read ina spectrophotometer at 370nm[30]. The results
are expressed as nanomoles carbonyl per milligram protein.
2.8.3. Thiobarbituric acid reactive species levels
To assess the extent of lipoperoxidation, the formation of
thiobarbituric acid reactive substances (TBARS) was evaluated
using a heated acidic reaction. This method has been widely
adopted tomeasure lipid redox states [31]. Kidney sampleswere
mixed with 0.6 mL of 10% trichloroacetic acid and 0.5 mL of
0.82% thiobarbituric acid and heated in a boiling water bath for
30 minutes. The TBARS levels were determined by measuring
the absorbance at 532 nm and using a calibration curve with
1,1,3,3-tetramethoxypropane as a standard. The results were
expressed as nanomoles TBARS per milligram protein.
2.8.4. Antioxidant enzyme activities
The catalase (EC 1.11.1.6) (CAT) activity was assayed by measur-
ing the rate of decrease in H2O2 absorbance at 240 nm, and the
results are expressed as units CAT per milligram protein
(Supplementary Fig. 1A) [32]. The SOD (EC 1.15.1.1) activity was
assessed by quantifying the inhibition of superoxide-dependent
adrenaline auto-oxidation at 480 nm, as previously described;
and the results were expressed as units SOD per milligram
protein (Supplementary Fig. 1B) [33]. The glutathione peroxidase
(EC 1.11.1.9) (GSH-Px) activitywasmeasured according toWendel
(Supplementary Fig. 1C) [34]. One unit of GSH-Px activity was
defined as 1 μmolNADPH consumedperminute, and the specific
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of the SOD/CAT/GHS-Px activities was evaluated to determine
the effects of the protocols on these 3 coordinated oxidant-
detoxifying enzyme activities, which act in sequence to convert
superoxide anions into water [35]. An imbalance among their
activities is thought to facilitate oxidative-dependent alter-
ations in the cellular environment, which may culminate in
oxidative stress.
2.9. Western blotting of proteins involved in AGEs (RAGE)
and redox (SOD2) homeostasis
Kidney samples homogenized in Laemmli sample buffer
(20 μg) were separated using sodium dodecyl sulfate poly-
acrylamide gel electrophoresis on 10% (w/v) acrylamide and
0.275% (w/v) bisacrylamide gels, and the proteins were then
electrotransferred onto nitrocellulose membranes. The mem-
branes were then incubated in Tris/saline buffer Tween-20
(20 mmol/L Tris-HCl, pH 7.5; 137 mmol/L NaCl; and 0.05% [v/v]
Tween 20) containing 1% (w/v) nonfat milk powder for 1 hour
at 25°C. The membranes were subsequently incubated for 12
hours with the appropriate primary antibody (SOD2, 1:2000;
RAGE, 1:5000; β-actin, 1:10000). After washing in Tris/saline
buffer Tween-20, the blots were incubated with horseradish
peroxidase–linked anti-immunoglobulin G antibodies for 1.5
hours at 25°C. Chemiluminescent bands were detected, and
densitometric analysis was performed using ImageJ software
(NIH, Bethesda, MD, USA) [23].
2.10. Inflammatory homeostasis
2.10.1. Tumor necrosis factor–α levels
The tumor necrosis factor–α (TNF-α) levels were measured using
a commercial kit for a sandwich enzyme-linked immunosorbent
assay according to the manufacturer's instructions (Invitrogen).
After homogenization, the kidney samples were centrifuged; an
aliquot of the supernatant was reserved for protein measure-
ment, and the remaining sample was stored at −80°C for further
TNF-α level quantification. The sampleswere readat 450nm.The
results are expressed as picograms per milligram protein [36].
2.11. Statistical analyses
All data are presented as the means ± SEM and analyzed using
the Statistical Package for the Social Sciences (SPSS version 20.0;
IBM, Chicago, IL, USA) software and Prism GraphPad Software
(version 5; SanDiego, CA,USA). Twogroupswere comparedusing
Student t test (P < .05) for glycemia after 1 week of saline (control)
or alloxan (diabetes induction) administration.
All others analyses comparing nondiabetic groups (>>C, HAGE,
and HAGE + n-3) or diabetic groups (Db, Db + HAGE, and Db +
HAGE + n-3) were performed using one-way analysis of variance
followed by Tukey post hoc test (P < .05).3. Results
The protocol for diabetes mellitus induction (alloxan) increased
the fasting glycemia levels by 5 times, measured 1 week later,
compared with the control group (Fig. 2A, P < .05). Fig. 2B showsthat hyperglycemia was maintained for up to 4 weeks. The
glycemia was not affected by the diets in either the control or
diabetic groups. Diabetes mellitus induction did not affect
the serum creatinine levels (Fig. 2C). However, the HAGE fat–
containing diet increased creatinine levels in the control and
diabetic groups (P < .05); this effect was eliminated in both groups
by dietary n-3. Thus, n-3 PUFAs did not attenuate the diabetes-
causing induction of hyperglycemia but did eliminate the dietary
effect of HAGE on creatinine serum levels. These results indicate
that n-3 PUFAs supplementation tends to not have an effect on
thediabetesmellitus inductionoutcomebut does tend to prevent
the renal alterations caused by the HAGE fat–containing diet.
Fig. 3 shows the effects of the protocols on the AGE
homeostasis system in the kidney. To assess themetabolism of
AGEs, the AGE compound N-(CM)L levels (Fig. 3A), the GLO1
activity (Fig. 3B), and the RAGE immunocontent (Fig. 3C) were
evaluated in rat kidneys. The N-(CM)L levels were increased
by both the diet (P < .05) and the induction of diabetes, and n-3
PUFAsprevented this effect only in thenondiabetic group (P< .05)
(Fig. 3A). The GLO1 activity was increased by both the HAGE
diet (P < .05) and diabetes; this effect was reverted by n-3 PUFAs
only in the diabetic group (Fig. 3B, P < .05). Fig. 3C shows that
the RAGE levels were increased by both the HAGE diet and
diabetes; n-3 PUFAs prevented this effect only in the Db + HAGE
group (P < .05) (Fig. 3C).
Figs. 4 and 5 illustrate the effects of the protocols on the
renal redox homeostasis. Fig. 4 shows the lipoperoxidation:
TBARS (A), ROS-DCFH (B), and protein carbonylation (C). The
TBARS levels were not affected by diabetes, but they were
increased by the HAGE diet in both the nondiabetic and
diabetic groups (P < .05); n-3 PUFAs eliminated this effect. The
DCFH oxidation (B) was increased by the HAGE diet in the
control group, as well as by diabetes induction (P < .05); these
effects were also eliminated by the n-3 PUFAs. The protein
carbonyl content (C) was increased only by the induction of
diabetes, and this effect was not modulated by the n-3 PUFAs.
Fig. 5 shows that the SOD/CAT + GSH-Px ratio (A) and the
SOD2 immunocontent (B) were increased only by the HAGE
diet in both the nondiabetic and diabetic groups; this effect
was abolished by the n-3 PUFAs.
To evaluate the effects of our experimental models on the
inflammatory status, the TNF-α levels (an inflammatorymarker)
were measured in the kidneys (Fig. 6). The TNF-α levels were
increased only by HAGE in both the nondiabetic and diabetic
groups (P < .05); this effect was also abolished by the n-3 PUFAs.
Importantly, n-3 PUFA supplementationwas effective against
a range of alterations promoted by both protocols. These al-
terations might occur through the RAGE/oxidative stress/TNF-α
axis and are more prominent in the HAGE fat–containing diet
protocol than in the diabetes mellitus induction protocol (Fig. 7).4. Discussion
In summary, thediabetes induction (Db) andHAGE fat–containing
diet (HAGE diet) protocols affected the renal parameters evalu-
ated in this study differently. Diabetes affected all of the in-
vestigated parameters of the AGE system (increased N-(CM)L
levels, RAGE immunocontent, andGLO1activity), aswell as redox
homeostasis (increasedDCFHoxidation and the protein carbonyl
0100
200
300
400
500
600
Saline
Alloxan 150 mg/ kg b.w.
+
+-
A
+
*
G
lu
co
se
 
(m
g 
/ d
L)
Co
ntr
ol
HA
GE
HA
GE
+n
-3
Dia
be
tic
Db
+H
AG
E
Db
+H
AG
E+
n-3
0
100
200
300
400
500B
G
lu
co
se
 
(m
g 
/ d
L)
Co
ntr
ol
HA
GE
HA
GE
+n
-3
Dia
be
tic
Db
+H
AG
E
Db
+H
AG
E+
n-3
0.00
0.25
0.50
0.75
1.00
1.25
* 
#
C
#
Cr
ea
tin
in
e 
(m
g 
/ d
L)
Fig. 2 – Glycemia 1 week after diabetes induction (A), glycemia (B), and serum creatinine levels of nondiabetic and diabetic rats
after 4 weeks of eating different diets: control, HAGE, or HAGE + n-3 diets.All results are expressed in milligrams per deciliter
and presented as the means ± SEM (n = 8/group). *P < .05 compared with the control group (A); #P < .05 compared with the
nondiabetics groups; *#P < .05 compared with the diabetics groups.
517N U T R I T I O N R E S E A R C H 3 5 ( 2 0 1 5 ) 5 1 2 – 5 2 2content), without affecting the inflammatory status (TNF-α
levels). The HAGE diet increased the serum levels of creatinine,
altered the metabolism of the AGEs (increased N-(CM)L, GLO1
activity, and RAGE levels in the control group), affected the redox
homeostasis (except for the protein carbonyl levels; increased
TBARS and SOD2 immunocontent levels, DCFH oxidation [in the
nondiabetic group], and the SOD/CAT + GSH-Px ratio), and
increased the TNF-α levels (as an index of the inflammatory
status). In our research hypothesis, we thought that the com-
bination of the 2 experimental protocols would lead to an
increase in renal dysfunction; but contrary to our hypothesis,
we found that the diet or the diabetes alone appeared to promote
major deleterious effects in the studied parameters. However,we
confirmed a part of our hypothesis that the n-3 PUFAs had
nephoprotective effects, n-3 PUFAsattenuating themostharmful
effects caused by our experimental protocols.
Diabetes-induced renal dysfunction is a progressive disease,
and earlier diagnosis can improve the success of treatment [37].
The limitation of this study is the short period of the experimen-
tal protocol because many studies demonstrated that rodents
with induced diabetes show renal damage immunohistochemi-
cally only after 8 weeks [38,39]; however, other studies have
shown that an increase in oxidative stress and inflammation
already exists in the first weeks after diabetes induction [40,41].
Serum creatinine is an inexpensive and readily available
physiological biomarker of kidney function and remains the
“criterion standard” test for diagnosing renal alterations [42,43].There is a relationship between AGE formation and deposi-
tion and renal physiology [44]. Here, rats receiving a HAGE fat–
containing diet exhibited increased GLO1 activity and RAGE
immunocontent in their kidneys; however, there was no effect
on the renal levels of N-(CM)L. This result could be explained by
the increased GLO1 activity. As observed in previous studies
[45], the high-fat diet was capable of inducing increased RAGE
levels in the kidneys. In addition, diabetes induced increases in
the GLO1 activity, N-(CM)L levels, and RAGE immunocontent.
Huang et al [46] also found increases in RAGE expression and
oxidative stress in streptozotocin-induced diabetic rats. Consis-
tent with our results, Wei et al [47] demonstrated that n-3 PUFAs
might prevent chronic allograft vasculopathy by downregulating
RAGE signaling.
Many pathological conditions, including diabetes mellitus,
have oxidative stress as a common feature, which is an im-
portant trigger for DNA damage, the apoptosis signaling cascade
and cellular death [48]. The HAGE fat–containing diet promoted
increased lipid peroxidation and ROS levels in rat kidneys of both
the nondiabetic and diabetic groups. Consistent with our results,
Scivittaro et al [49] found a dose-response relationship between
the AGE content and the ROS levels. Here, this increase was
prevented by dietary n-3 PUFAs, indicating that they may have
beneficial effects against the oxidative stress induced by the
HAGE fat–containing diet. In this context, An et al [50] demon-
strated that n-3 PUFAs might inhibit pro-oxidant and proin-
flammatory pathways. Furthermore, the increased protein
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the diets.
A misbalance in the activity of the enzymatic antioxidant
system has been associated with many pathological chronic
kidney conditions in both diabetic patients and rodent models
[51,52]. The AGEs appear to directly affect the enzymatic anti-
oxidant system, as observed in studies using AGE-enriched diets
[23] as well as in cultured cells [49]. The SOD/CAT + GSH-Px ratio
represents the antioxidant homeostasis. We showed that this
ratio was increased in the HAGE groups (diabetic and nondia-
betic) and that this effect was eliminated by the n-3 PUFAs.
These results indicate that the SOD activity may increase more
than the CAT and GSH-Px activities; thus, CAT and GSH-Px
could notmetabolize the H2O2 produced by SOD. In this context,
we showed an increase in the expression of SOD2 (Mn-SOD)
caused by the HAGE fat–containing diet in both the nondiabetic
and diabetic groups; the n-3 PUFAs prevented this increase in
both groups. Our results were consistent with those of Ruggiero
et al [53], who found that a high-fat diet induced increased SOD2
expression in mice. Likewise, in agreement with our results,
Fujita et al [54] observed that only diabetic conditions seemed to
not affect SOD2 expression.
An et al [50] showed an important anti-inflammatory
effect of n-3 PUFAs in animals with chronic kidney disease.
Similarly, Garman et al [55] stated that n-3 PUFAs decreased thedevelopment of renal disease in streptozotocin-induced dia-
betic rats. In our study, the n-3 PUFAs prevented the TNF-α
increase that was exerted by the HAGE fat–containing diet in
both the nondiabetic and diabetic groups. Our results are
consistentwith previous studies that foundpreventive features
of n-3 PUFAs toward chronic kidney disease in animal [50,55]
and human studies [56].
The binding of AGEs to cell membrane receptor(s) (RAGE)
leads to the activation ofNADPHoxidase, a potent inducer of ROS
formation [44]. An increase in ROS levels may lead to the
activation of the cytoplasmic complex NF-κB via the MAP kinase
pathway [49,57]. Nuclear factor–κB is translocated to the nucleus,
where it binds to DNA sequences and activates the transcription
of theNF-κB–regulated target genes, suchasTNF-α, interleukin-6,
and RAGE [58,59]. The exacerbated production of TNF-α may
lead to an intracellular proinflammatory state; and the augment-
ed RAGE production may facilitate AGE binding, sustaining
higher AGE effects. n-3 Polyunsaturated fatty acids may be
effective in preventing the increase in TNF-α and the expression
of RAGE, thereby inhibiting proinflammatory pathways. Further-
more, we suggest that n-3 PUFAs may have an important
antioxidant effect by decreasing ROS production, which is the
trigger for various deleterious effects in the kidney. Consistent
with our results, Diaz Encarnacion et al [60] proposed that n-3
PUFAs might suppress TNF-α–stimulated MCP-1 transcription in
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dependent fashion.
The beneficial effects of dietary n-3 PUFAs depended on
whether the impairments were caused by the induction of
diabetes and/or by the HAGE fat–containing diet. n-3 Polyun-
saturated fatty acids more robustly eliminated the HAGE fat–
containing diet effects (specifically the serum creatinine levels,GLO1 activity, TBARS levels, DCFHoxidation, SOD/CAT+GSH-Px
ratio, and SOD2 and TNF-α levels) in the nondiabetic group
rather than the specific effects caused by the induction of
diabetes (n-3 PUFAs did not affect the hyperglycemia or the N-
(CM)L and protein carbonyl levels). When the investigated
parameters were altered by the HAGE fat–containing diet in
rats submitted to diabetes induction, the effects of dietary n-3
PUFAs played a slighter protective role (they eliminated the
increased GLO1 activity and DCFH oxidation in both groups and
the increased RAGE levels only in the diabetic group). Thus, n-3
PUFAshad clear effects; and although theywere exerted against
both the inductionof diabetes and theHAGE fat–containingdiet,
they were more prominent against the HAGE fat–containing
diet. This finding reinforces the data in the literature indicating
the beneficial role of n-3 PUFAs in the clinical and preclinical
nutrition against pathological conditions [56,61].
In summary, this study showed that the extrinsic AGE
pathway (diet) had a greater effect on renal metabolism than
the intrinsic AGE pathway (diabetes induction) and that n-3
PUFAs appear to prevent kidney dyshomeostasis via antiox-
idant and anti-inflammatory pathways. Our results suggest
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520 N U T R I T I O N R E S E A R C H 3 5 ( 2 0 1 5 ) 5 1 2 – 5 2 2that n-3 PUFA supplementation may be relevant as an
adjuvant treatment in some pathological conditions, such as
chronic kidney diseases and renal failure, as well as in some
harmful diets (dietary AGEs). However, the mechanism
through which the n-3 PUFAs act on the RAGE/oxidative
stress/TNF-α axis must still be studied.ROS
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